title: Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission.
authors.affiliation: Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. hjconter@mdanderson.org
authors.forename: Henry J
authors.initials: HJ
authors.lastname: Conter
authors.forename: Zita D
authors.initials: ZD
authors.lastname: Lim
authors.forename: Chaan S
authors.initials: CS
authors.lastname: Ng
authors.forename: Randall E
authors.initials: RE
authors.lastname: Millikan
authors.forename: Nizar M
authors.initials: NM
authors.lastname: Tannir
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D007155:Immunologic Factors; D016898:Interferon-alpha; D003841:Deoxycytidine; D005472:Fluorouracil; D000093542:Gemcitabine
keywords: 5-Fluorouracil; Biochemotherapy; Gemcitabine; Interferon-alfa; Metastatic Carcinoma; Sarcomatoid Renal Cell carcinoma